It is recognised that the cytotoxicity of a number of xenobiotics is mediated through the production of reactive metabolites (1). Given this, and the current emphasis on the development of in vitro tests for assessment of xenobiotic cytotoxicity (2), it is of considerable interest to develop systems for the detection in vitro of cytotoxic reactive metabolites. Indeed, it would seem appropriate to employ a limited battery of tests for detection of xenobiotic-mediated cytotoxicity, some of which would be dedicated to assessment of the role of metabolism in such toxicity. The aim of this review is to identify and discuss the approaches currently being employed to this end, and to suggest some possible future trends.
GuengerichF.P., and LieblerD.C. (1985). Enzymatic activation of chemicals to toxic metabolites.CRC Critical Reviews in Toxicology14, 259–307.
2.
KnoxP., UphillP.F., FryJ.R., BenfordD.J., and BallsM. (1986). The FRAME multicentre project on in vitro cytotoxicity.Food and Chemical Toxicology24, 457–463.
3.
ReedD.J., and FarissM.W. (1984). Glutathione depletion and susceptibility.Pharmacological Reviews36, 25S–33S.
4.
GorrodJ.W. (1981). Covalent binding as an indicator of drug toxicity. In Testing for Toxicity (ed. GorrodJ.W.), pp. 77–93. London: Taylor & Francis Ltd.
5.
MaronD.M., and AmesB.N. (1983). Revised methods for the Salmonella mutagenicity test.Mutation Research113, 173–215.
6.
FryJ.R. (1982). Activation systems in tissue culture toxicity studies.Toxicology25, 1–12.
7.
MyhrB.C., and MayoJ.K. (1987). Mutagenicity of rat liver S9 to L5178Y mouse lymphoma cells.Mutation Research189, 27–37.
8.
PaoliniM., BauerC., CorsiC., Del CarratoreR., NieriR., and BronzettiG. (1983). Stability of microsomal monooxygenase during incubations for the liver microsomal assay with S9 fractions of mouse liver under various conditions.Mutation Research110, 221–230.
9.
BenedettiA., CasiniA.F., and FerraliM. (1977). Red cell lysis coupled to the peroxidation of liver microsomal lipids.Research Communication in Chemical Pathology and Pharmacology17, 519–528.
10.
RodersM.K., GlendeE.A., and RecknagelR.O. (1978). NADPH-dependent microsomal lipid peroxidation and the problem of pathological action at a distance.Biochemical Pharmacology27, 437–443.
11.
WeaverF.A., TorkelsonA.R., ZygmuntW.A., and BrowderH.P. (1978). Tissue culture cytotoxicity assay for cyclophosphamide metabolites in rat body fluids.Journal of Pharmaceutical Science67, 1009–1012.
12.
MonksT.J., LauS.S., and GilletteJ.R. (1984). Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene.Journal of Pharmacology and Experimental Therapeutics228, 393–399.
13.
LauS.S., MonksT.J., GreenK.E., and GilletteJ.R. (1984). Detection and half-life of bromobenzene-3,4-oxide in blood.Xenobiotica14, 539–543.
14.
MinerD.J., and KissingerP.T. (1979). Evidence for the involvement of N-acetyl-p-quinoneimine in acetaminophen metabolismBiochemical Pharmacology28, 3285–3290.
15.
HornerS.A., FryJ.R., ClothierR.H., and BallsM. (1985). A comparison of two cytotoxicity assays for the detection of metabolism-mediated toxicity in vitro: a study with cyclophosphamide.Xenobiotica15, 681–686.
16.
HornerS.A., FryJ.R., ClothierR.H., and BallsM. (1987). The detection of cytotoxicity produced by short-lived reactive intermediates: a study with bromobenzene.Xenobiotica17, 777–782.
17.
HornerS.A., ZuccoF., FryJ.R., ClothierR.H., and BallsM. (1987). Investigation of the cytotoxicity produced by generation of short-lived reactive metabolites in vitro: a study with paracetamol.Toxicology In Vitro1, 133–138.
18.
DybingE., HolmeJ.A., GordonW.P., SoderlundE.J., DahlinD.C., and NelsonS.D. (1984). Genotoxicity studies with paracetamol.Mutation Research138, 21–32.
19.
HolmeJ.A., DahlinD.C., NelsonS.D., and DybingE. (1984). Cytotoxic effects of N-acetyl-p-benzoquinoneimine, a common arylating intermediate of paracetamol and N-hydroxyparacetamol.Biochemical Pharmacology33, 401–406.
20.
HoffmanK.J., StreeterA.J., AxworthyD.B., and BaillieR.A. (1985). Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins.Molecular Pharmacology27, 566–573.
21.
SpielbergS.P. (1980). Acetaminophen toxicity in human lymphocytes in vitro.Journal of Pharmacology and Experimental Therapeutics213, 395–398.
22.
SpielbergS.P. (1985). Acetaminophen toxicity in lymphocytes heterozygous for glutathione synthetase deficiency.Canadian Journal of Physiology and Pharmacology63, 468–471.
23.
SuolinnaE.M. (1982). Isolation and culture of liver cells and their use in the biochemical research of xenobiotics.Medical Biology60, 237–254.
24.
DaletC., FehlmannM., and DelseyP. (1982). Use of percoll density gradient centrifugation for preparing isolated rat hepatocytes having long-term viability.Analytical Biochemistry16, 119–123.
25.
FryJ.R., WiebkinP., and BridgesJ.W. (1980). 7-Ethoxycoumarin 0-deethylase induction by phenobarbitone and 1,2-benzanthracene in primary maintenance cultures of adult rat hepatocytes.Biochemical Pharmacology29, 577–581.
26.
WarrenM., and FryJ.R. (1988). Influence of medium composition on 7-alkoxycoumarin 0-dealkylase activities of rat hepatocytes in primary maintenance culture.Xenobiotica, in press.
27.
AikawaK., SatohT., KobayashiK., and KitigawaH. (1978). Glutathione depletion by aniline analogs in vitro associated with liver microsomal cytochrome P450.Japanese Journal of Pharmacology28, 699–705.
28.
GarleM.J., KhanJ., and FryJ.R. (1988). Depletion of glutathione by the hepatotoxins paracetamol and bromobenzene, and their non-hepatotoxic analogues, in a fortified liver microsomal system.Toxicology In Vitro, in press.
29.
GarleM.J., and FryJ.R. (1988). Detection of reactive metabolites in vitro.Toxicology, in press.
